Third Seven Capital

Four Springs Capital Trust is a private real estate investment firm based in Lake Como, New Jersey, established in 2012. The company specializes in acquiring and managing a diversified portfolio of single-tenant net lease properties, focusing on sectors such as industrial, medical, retail, and office spaces. It targets high-quality tenants and seeks properties with remaining lease terms exceeding ten years, which include contractual rent increases. By actively managing its portfolio, Four Springs Capital Trust aims to provide a stable and diversified tenant base, catering to the income-producing commercial real estate market across the United States.

Vinci Pharmaceuticals is a healthcare company focused on developing innovative treatments for retinal diseases, particularly those that can lead to blindness in individuals with intermediate-stage conditions. The company operates at the pre-clinical stage, utilizing a proprietary platform that features implant technology designed to deliver drugs directly to targeted tissues within the retina. This approach aims to provide safe, durable, and minimally invasive therapeutic options, enhancing patient outcomes in the field of ophthalmology.

Newlight Technologies, Inc. is a biotechnology company focused on converting greenhouse gases into sustainable plastics through its innovative bioconversion technology. Founded in 2003 and based in Huntington Beach, California, the company utilizes a proprietary carbon capture process to produce AirCarbon, a high-performance thermoplastic derived from air and methane emissions. AirCarbon serves as a renewable alternative to traditional fossil fuel-based plastics, including polypropylene, polyethylene, ABS, polystyrene, and TPU. By leveraging decarbonization technology, Newlight aims to replace oil-based plastics on a global scale, contributing to a reduction in atmospheric carbon while promoting market-driven solutions for a more sustainable future.

UDIS Capital Partners LLC is a boutique investment management consultancy based in New York, incorporated in 2016. The firm focuses on business development for investment management companies, facilitating growth through a global perspective. UDIS specializes in introducing both foreign and domestic capital, managing cross-border transactions, and providing foreign currency solutions. By enabling international and domestic deal flow, UDIS Capital Partners connects investors with investment professionals, enhancing opportunities in the investment management sector.

Wunderkind, Inc. is a technology company that specializes in cloud-based solutions for customer acquisition and behavioral marketing automation. Founded in 2010 and headquartered in New York City, with an additional office in London, Wunderkind offers a platform known as BounceX, which focuses on people-based marketing. This platform enables online publishers and retail website owners to engage visitors through targeted messaging and timely advertising, ultimately enhancing conversion rates and increasing revenue. Wunderkind's technology leverages real-time user behavior data, such as mouse movements and intent signals, to identify potential customers and deliver personalized experiences across various channels, including websites, email, and advertisements. The company's impressive client roster includes well-known brands like Uniqlo, Lufthansa, and CNN, and it is recognized for driving significant revenue growth for these businesses through its innovative marketing solutions.

Steele Creek has an investment objective to generate current income by investing primarily in fixed-income instruments, including broadly syndicated bank loans, structured products, mezzanine financings, and secured bonds. It is a business development company that invests in bank loans and structured products.

EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market. The company's patented technology allows the practitioner to deliver whole or partial breast irradiation while minimizing exposure to critical structures at risks such as lung, heart, and skin, and lowering the whole-body dose to the patient. By offering these advantages, clinicians can apply novel approaches such as accelerated radiation treatment to reduce procedure time as well as allowing for advanced techniques such as stereotactic radiation therapy.

Fund That Flip, Inc. is an online investment platform specializing in short-term loans for residential real estate redevelopment projects. Founded in 2014 and headquartered in New York City, with additional offices in Cleveland, Ohio, the company connects accredited investors with real estate redevelopers by underwriting and originating projects. Fund That Flip focuses on facilitating investments in borrower-dependent notes, allowing investors to participate in the residential rehab loan market. The platform aims to generate passive wealth for peer-to-peer lenders while contributing to community restoration efforts across the United States through its network of experienced redevelopers. Fund That Flip has been recognized for its rapid growth, earning a spot on the 2019 Inc. 500 list of the nation's fastest-growing private companies.

HFactor is a company based in Bryn Mawr, Pennsylvania, specializing in the production of hydrogen-infused water. As a pioneer in the functional beverage sector, HFactor offers antioxidant-rich drinking water that is designed to promote health and wellness. The company emphasizes sustainability through its ergonomic and eco-friendly packaging, which aims to minimize environmental impact. HFactor is dedicated to delivering high-quality hydrogen water, positioning itself as a leader in this innovative market.

Armis Biopharma, Inc. is a biopharmaceutical company focused on developing and commercializing late-stage clinical products and antimicrobial therapies to combat antibiotic resistance and healthcare-associated infections. The company's key offerings include Ximycin, a patented localized antimicrobial therapy designed for broad-spectrum polymicrobial coverage at incision sites to prevent multi-drug resistant surgical site infections, and Veriox, a chemical platform utilizing peracid technology that provides effective treatment for infections while delivering positive effects on tissue. Armis Biopharma is dedicated to offering innovative non-systemic, non-resistant anti-infective therapeutics aimed at addressing the urgent challenges posed by resistant pathogens, with applications in the wound, orthopedic, and dermatology markets. Founded in 1997, the company is headquartered in Fort Collins, Colorado.